ARTICLE | Clinical News
BF-389: To begin a Phase I trial in October
September 7, 1993 7:00 AM UTC
Biofor Inc., unit of Scherer Healthcare Inc. (SCHR) Product: BF-389, multiple inhibitor of inflammatory enzymes Indication: Treat arthritis Status: To begin a Phase I trial in October ...